FdaApplication

ANDA 210156

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTORRENT PHARMACEUTICALS LTD
application_typeANDA
approval_date2024-12-17

Products (2)

ProductActive ingredientStrengthDosage form
APIXABANAPIXABAN5MGTABLET;ORAL
APIXABANAPIXABAN2.5MGTABLET;ORAL

2 products